MICHELLE AHLERS: Open Payments
NPI 1568129146 · FAYETTEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$682 in 23 payments from 10 companies in 2025. Trend: 2023 $257 · 2024 $562 · 2025 $682
Food & beverage: $682
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $175 |
| Janssen Biotech, Inc. | 5 | $127 |
| Melinta Therapeutics, LLC | 1 | $122 |
| ABBVIE INC. | 4 | $68 |
| PFIZER INC. | 3 | $52 |
| QOL Medical, LLC | 2 | $47 |
| Ardelyx, Inc. | 2 | $40 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| IRONWOOD PHARMACEUTICALS, INC | 1 | $18 |
| Cumberland Pharmaceuticals, Inc. | 1 | $15 |
Products named: DUPIXENT, TREMFYA, Rezzayo, XELJANZ, Sucraid, IBSRELA, MAVYRET, CREON.
Industry payments across NC — which companies pay providers there.
